EUVIMEDAtrasti EUVIMED
Open access · CC BY-NC-ND 4.0

Cost effectiveness analysis of drug coated balloon only angioplasty for de novo coronary artery disease

Ioannis Merinopoulos iD, Tharusha Gunawardena, Natasha Corballis, Vasiliki Tsampasian, Vassilios Vassiliou iD, Simon Eccleshall, Alisdair Ryding, George Xydopoulos

Catheterization and Cardiovascular Interventions · 2023

DOI: 10.1002/ccd.30878 ↗

At a glance

Journal article in Catheterization and Cardiovascular Interventions, 2023. Written by Ioannis Merinopoulos and 7 co-authors. Institution: Department of Cardiology, Norfolk and Norwich University Hospital, Norwich, UK. Major MEDLINE topics: Coronary Artery Disease, Drug-Eluting Stents, Angioplasty, Balloon, Coronary, Coronary Restenosis. Cited 4 times so far (Crossref); 15 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Institute for Health Research Capability Fund from Norfolk and Norwich University Hospital, B. Braun Medical.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Aims

We aimed to perform a cost analysis of drug coated balloon (DCB)‐only angioplasty versus drug eluting stent (DES), for de novo disease of all vessel sizes and all clinical indications.

Background

DCB angioplasty is an emergent technology for the treatment of coronary artery disease. There is lack of data regarding the cost‐effectiveness of DCB‐only angioplasty for treatment of de novo coronary artery disease as compared with second generation DES.

Methods

We compared total costs of patients treated with DCB or DES for first presentation of ST‐elevation myocardial infarction, non‐ST‐elevation myocardial infarction, or stable angina due to de novo disease between January 1, 2018 and November 15, 2019. We defined total cost as the sum of (1) procedural devices‐cost, (2) procedural staff‐cost, (3) post‐percutaneous coronary intervention hospital stay cost, and (4) antiplatelet regime cost. A cost minimization analysis was performed to compare the costs of DCB and DES.

Results

We present 1952 all‐comer, consecutive patients; 902 (1064 lesions) treated with DCB and 1050 (1236 lesions) treated with DES for de novo coronary artery disease. The cost per patient was estimated to be £9.02 more expensive in the DCB group (£3153.00 vs. £3143.98). However, the cost per lesion treated was calculated to be £15.51 cheaper in the DCB group (£3007.56 vs. £3023.07). The results were consistent irrespective of duration of long‐term antiplatelet medications.

Conclusion

We have compared the cost‐effectiveness of DCB‐only angioplasty to DES‐angioplasty and showed that the per patient and per lesion results were not different and hence cost should not be implicated in the decision to choose DCB or DES.

Subjects

MeSH terms (MEDLINE)

Coronary Artery DiseaseDrug-Eluting StentsAngioplasty, Balloon, CoronaryCoronary RestenosisAngioplasty, BalloonHumansCost-Effectiveness AnalysisTreatment OutcomeCoated Materials, Biocompatible

Author keywords

cost analysisdrug coated balloondrug eluting stent

Substances

Coated Materials, Biocompatible

Authors and institutions

  • Department of Cardiology, Norfolk and Norwich University Hospital, Norwich, UK.
  • Norwich Medical School, University of East Anglia, Norwich, UK.

ORCID profiles: Ioannis Merinopoulos, Vassilios Vassiliou

Funding

  • National Institute for Health Research Capability Fund from Norfolk and Norwich University Hospital
  • B. Braun Medical

Cite

APA

Merinopoulos, I., Gunawardena, T., Corballis, N., Tsampasian, V., Vassiliou, V., Eccleshall, S., Ryding, A., & Xydopoulos, G. (2023). Cost effectiveness analysis of drug coated balloon only angioplasty for de novo coronary artery disease. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30878

Vancouver

Merinopoulos I, Gunawardena T, Corballis N, Tsampasian V, Vassiliou V, Eccleshall S, et al. Cost effectiveness analysis of drug coated balloon only angioplasty for de novo coronary artery disease. Catheterization and Cardiovascular Interventions. 2023. doi:10.1002/ccd.30878

BibTeX
@article{Merinopoulos2023,
  author = {Merinopoulos, Ioannis and Gunawardena, Tharusha and Corballis, Natasha and Tsampasian, Vasiliki and Vassiliou, Vassilios and Eccleshall, Simon and Ryding, Alisdair and Xydopoulos, George},
  title = {Cost effectiveness analysis of drug coated balloon only angioplasty for de novo coronary artery disease},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2023},
  doi = {10.1002/ccd.30878}
}
Start for free →